People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RedHill Biopharma Ltd. | — | Pharmaceuticals | Series C | $72.5M | $101.6M | 2013 |
Dror Ben Asher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dror Ben Asher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Reed | 1 | 2 |
| June Almenoff | 1 | 2 |
| GILEAD RADAY | 1 | 2 |
| Shmuel Cabilly | 1 | 2 |
| Alla Felder | 1 | 2 |
| Rick D Scruggs | 1 | 2 |
| Adi Frish | 1 | 1 |
| Ofer Tsimchi | 1 | 1 |
| Ori Shilo | 1 | 1 |
| Guy Goldberg | 1 | 1 |
| Uri Hananel Aharon | 1 | 1 |
| Dan Suesskind | 1 | 1 |
| Gilead D Raday | 1 | 1 |
| Guy D Goldberg | 1 | 1 |
| Razi Ingber | 1 | 1 |
| Rick Scruggs | 1 | 1 |
| Micha Ben Chorin | 1 | 1 |
| June D Almenoff | 1 | 1 |
| Reza D Fathi | 1 | 1 |
| Nicolas D Weinstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.